This report aims to provide a comprehensive presentation of the global market for Influenza Antiviral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Antiviral Drugs. This report contains market size and forecasts of Influenza Antiviral Drugs in global, including the following market information:
Global Influenza Antiviral Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Influenza Antiviral Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oseltamivir Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Influenza Antiviral Drugs include GSK, Boehringer Ingelheim, Merck, Novartis, Beximco Pharmaceuticals, Pfizer, Roche, Johnson & Johnson and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Influenza Antiviral Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Antiviral Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Influenza Antiviral Drugs Market Segment Percentages, by Type, 2022 (%)
Oseltamivir
Zanamivir
Peramivir
Adamantanes
Others
Global Influenza Antiviral Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Influenza Antiviral Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others
Global Influenza Antiviral Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Influenza Antiviral Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza Antiviral Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Influenza Antiviral Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Johnson & Johnson
Sanofi
Cipla Limited
Natco Pharma
Seqirus
Adamas Pharmaceuticals, Inc.
Teva Pharmaceuticals
Daiichi Sankyo Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Influenza Antiviral Drugs, market overview.
Chapter 2: Global Influenza Antiviral Drugs market size in revenue.
Chapter 3: Detailed analysis of Influenza Antiviral Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Influenza Antiviral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Influenza Antiviral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Antiviral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Antiviral Drugs Overall Market Size
2.1 Global Influenza Antiviral Drugs Market Size: 2022 VS 2029
2.2 Global Influenza Antiviral Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Influenza Antiviral Drugs Players in Global Market
3.2 Top Global Influenza Antiviral Drugs Companies Ranked by Revenue
3.3 Global Influenza Antiviral Drugs Revenue by Companies
3.4 Top 3 and Top 5 Influenza Antiviral Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Influenza Antiviral Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Influenza Antiviral Drugs Players in Global Market
3.6.1 List of Global Tier 1 Influenza Antiviral Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Influenza Antiviral Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Antiviral Drugs Market Size Markets, 2022 & 2029
4.1.2 Oseltamivir
4.1.3 Zanamivir
4.1.4 Peramivir
4.1.5 Adamantanes
4.1.6 Others
4.2 By Type - Global Influenza Antiviral Drugs Revenue & Forecasts
4.2.1 By Type - Global Influenza Antiviral Drugs Revenue, 2018-2023
4.2.2 By Type - Global Influenza Antiviral Drugs Revenue, 2024-2029
4.2.3 By Type - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Antiviral Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Pharmacies
5.1.6 Others
5.2 By Application - Global Influenza Antiviral Drugs Revenue & Forecasts
5.2.1 By Application - Global Influenza Antiviral Drugs Revenue, 2018-2023
5.2.2 By Application - Global Influenza Antiviral Drugs Revenue, 2024-2029
5.2.3 By Application - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Influenza Antiviral Drugs Market Size, 2022 & 2029
6.2 By Region - Global Influenza Antiviral Drugs Revenue & Forecasts
6.2.1 By Region - Global Influenza Antiviral Drugs Revenue, 2018-2023
6.2.2 By Region - Global Influenza Antiviral Drugs Revenue, 2024-2029
6.2.3 By Region - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Influenza Antiviral Drugs Revenue, 2018-2029
6.3.2 US Influenza Antiviral Drugs Market Size, 2018-2029
6.3.3 Canada Influenza Antiviral Drugs Market Size, 2018-2029
6.3.4 Mexico Influenza Antiviral Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Influenza Antiviral Drugs Revenue, 2018-2029
6.4.2 Germany Influenza Antiviral Drugs Market Size, 2018-2029
6.4.3 France Influenza Antiviral Drugs Market Size, 2018-2029
6.4.4 U.K. Influenza Antiviral Drugs Market Size, 2018-2029
6.4.5 Italy Influenza Antiviral Drugs Market Size, 2018-2029
6.4.6 Russia Influenza Antiviral Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Influenza Antiviral Drugs Market Size, 2018-2029
6.4.8 Benelux Influenza Antiviral Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Influenza Antiviral Drugs Revenue, 2018-2029
6.5.2 China Influenza Antiviral Drugs Market Size, 2018-2029
6.5.3 Japan Influenza Antiviral Drugs Market Size, 2018-2029
6.5.4 South Korea Influenza Antiviral Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Influenza Antiviral Drugs Market Size, 2018-2029
6.5.6 India Influenza Antiviral Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Influenza Antiviral Drugs Revenue, 2018-2029
6.6.2 Brazil Influenza Antiviral Drugs Market Size, 2018-2029
6.6.3 Argentina Influenza Antiviral Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Influenza Antiviral Drugs Revenue, 2018-2029
6.7.2 Turkey Influenza Antiviral Drugs Market Size, 2018-2029
6.7.3 Israel Influenza Antiviral Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Influenza Antiviral Drugs Market Size, 2018-2029
6.7.5 UAE Influenza Antiviral Drugs Market Size, 2018-2029
7 Influenza Antiviral Drugs Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Influenza Antiviral Drugs Major Product Offerings
7.1.4 GSK Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Influenza Antiviral Drugs Major Product Offerings
7.2.4 Boehringer Ingelheim Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Influenza Antiviral Drugs Major Product Offerings
7.3.4 Merck Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Influenza Antiviral Drugs Major Product Offerings
7.4.4 Novartis Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Beximco Pharmaceuticals
7.5.1 Beximco Pharmaceuticals Company Summary
7.5.2 Beximco Pharmaceuticals Business Overview
7.5.3 Beximco Pharmaceuticals Influenza Antiviral Drugs Major Product Offerings
7.5.4 Beximco Pharmaceuticals Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.5.5 Beximco Pharmaceuticals Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Influenza Antiviral Drugs Major Product Offerings
7.6.4 Pfizer Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Influenza Antiviral Drugs Major Product Offerings
7.7.4 Roche Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Influenza Antiviral Drugs Major Product Offerings
7.8.4 Johnson & Johnson Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Influenza Antiviral Drugs Major Product Offerings
7.9.4 Sanofi Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Cipla Limited
7.10.1 Cipla Limited Company Summary
7.10.2 Cipla Limited Business Overview
7.10.3 Cipla Limited Influenza Antiviral Drugs Major Product Offerings
7.10.4 Cipla Limited Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.10.5 Cipla Limited Key News & Latest Developments
7.11 Natco Pharma
7.11.1 Natco Pharma Company Summary
7.11.2 Natco Pharma Business Overview
7.11.3 Natco Pharma Influenza Antiviral Drugs Major Product Offerings
7.11.4 Natco Pharma Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.11.5 Natco Pharma Key News & Latest Developments
7.12 Seqirus
7.12.1 Seqirus Company Summary
7.12.2 Seqirus Business Overview
7.12.3 Seqirus Influenza Antiviral Drugs Major Product Offerings
7.12.4 Seqirus Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.12.5 Seqirus Key News & Latest Developments
7.13 Adamas Pharmaceuticals, Inc.
7.13.1 Adamas Pharmaceuticals, Inc. Company Summary
7.13.2 Adamas Pharmaceuticals, Inc. Business Overview
7.13.3 Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Major Product Offerings
7.13.4 Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.13.5 Adamas Pharmaceuticals, Inc. Key News & Latest Developments
7.14 Teva Pharmaceuticals
7.14.1 Teva Pharmaceuticals Company Summary
7.14.2 Teva Pharmaceuticals Business Overview
7.14.3 Teva Pharmaceuticals Influenza Antiviral Drugs Major Product Offerings
7.14.4 Teva Pharmaceuticals Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.14.5 Teva Pharmaceuticals Key News & Latest Developments
7.15 Daiichi Sankyo Company
7.15.1 Daiichi Sankyo Company Company Summary
7.15.2 Daiichi Sankyo Company Business Overview
7.15.3 Daiichi Sankyo Company Influenza Antiviral Drugs Major Product Offerings
7.15.4 Daiichi Sankyo Company Influenza Antiviral Drugs Revenue in Global Market (2018-2023)
7.15.5 Daiichi Sankyo Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Influenza Antiviral Drugs Market Opportunities & Trends in Global Market
Table 2. Influenza Antiviral Drugs Market Drivers in Global Market
Table 3. Influenza Antiviral Drugs Market Restraints in Global Market
Table 4. Key Players of Influenza Antiviral Drugs in Global Market
Table 5. Top Influenza Antiviral Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Influenza Antiviral Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Influenza Antiviral Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Influenza Antiviral Drugs Product Type
Table 9. List of Global Tier 1 Influenza Antiviral Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Antiviral Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Influenza Antiviral Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Influenza Antiviral Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Influenza Antiviral Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Influenza Antiviral Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Influenza Antiviral Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Influenza Antiviral Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Influenza Antiviral Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Influenza Antiviral Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Influenza Antiviral Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Influenza Antiviral Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Influenza Antiviral Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Influenza Antiviral Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Influenza Antiviral Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Influenza Antiviral Drugs Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Influenza Antiviral Drugs Product Offerings
Table 32. GSK Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Influenza Antiviral Drugs Product Offerings
Table 36. Boehringer Ingelheim Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Influenza Antiviral Drugs Product Offerings
Table 40. Merck Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Influenza Antiviral Drugs Product Offerings
Table 44. Novartis Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Beximco Pharmaceuticals Company Summary
Table 47. Beximco Pharmaceuticals Influenza Antiviral Drugs Product Offerings
Table 48. Beximco Pharmaceuticals Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Beximco Pharmaceuticals Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Influenza Antiviral Drugs Product Offerings
Table 52. Pfizer Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Influenza Antiviral Drugs Product Offerings
Table 56. Roche Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Influenza Antiviral Drugs Product Offerings
Table 60. Johnson & Johnson Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Influenza Antiviral Drugs Product Offerings
Table 64. Sanofi Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Cipla Limited Company Summary
Table 67. Cipla Limited Influenza Antiviral Drugs Product Offerings
Table 68. Cipla Limited Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Cipla Limited Key News & Latest Developments
Table 70. Natco Pharma Company Summary
Table 71. Natco Pharma Influenza Antiviral Drugs Product Offerings
Table 72. Natco Pharma Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Natco Pharma Key News & Latest Developments
Table 74. Seqirus Company Summary
Table 75. Seqirus Influenza Antiviral Drugs Product Offerings
Table 76. Seqirus Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Seqirus Key News & Latest Developments
Table 78. Adamas Pharmaceuticals, Inc. Company Summary
Table 79. Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Product Offerings
Table 80. Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Adamas Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Teva Pharmaceuticals Company Summary
Table 83. Teva Pharmaceuticals Influenza Antiviral Drugs Product Offerings
Table 84. Teva Pharmaceuticals Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Teva Pharmaceuticals Key News & Latest Developments
Table 86. Daiichi Sankyo Company Company Summary
Table 87. Daiichi Sankyo Company Influenza Antiviral Drugs Product Offerings
Table 88. Daiichi Sankyo Company Influenza Antiviral Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Daiichi Sankyo Company Key News & Latest Developments
List of Figures
Figure 1. Influenza Antiviral Drugs Segment by Type in 2022
Figure 2. Influenza Antiviral Drugs Segment by Application in 2022
Figure 3. Global Influenza Antiviral Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Influenza Antiviral Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Influenza Antiviral Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Influenza Antiviral Drugs Revenue in 2022
Figure 8. By Type - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Influenza Antiviral Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Influenza Antiviral Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 16. US Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 28. China Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Influenza Antiviral Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Influenza Antiviral Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Beximco Pharmaceuticals Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Cipla Limited Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Natco Pharma Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Seqirus Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Adamas Pharmaceuticals, Inc. Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Teva Pharmaceuticals Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Daiichi Sankyo Company Influenza Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
